Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here